Wolverine Trading’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,800
Closed -$346K 5412
2024
Q3
$346K Sell
11,800
-4,000
-25% -$103K ﹤0.01% 3449
2024
Q2
$302K Buy
+15,800
New +$403K ﹤0.01% 3380
2022
Q1
Sell
-9,700
Closed -$268K 5675
2021
Q4
$268K Buy
+9,700
New +$278K ﹤0.01% 4307
2020
Q3
Sell
-38,900
Closed -$266K 4688
2020
Q2
$266K Buy
+38,900
New +$261K ﹤0.01% 3476
2020
Q1
Sell
-14,800
Closed -$134K 4782
2019
Q4
$134K Sell
14,800
-5,400
-27% -$43.9K ﹤0.01% 4193
2019
Q3
$146K Sell
20,200
-3,900
-16% -$28K ﹤0.01% 3729
2019
Q2
$192K Buy
+24,100
New +$285K ﹤0.01% 3744
2019
Q1
Sell
-11,400
Closed -$225K 4721
2018
Q4
$225K Sell
11,400
-900
-7% -$20.8K ﹤0.01% 3571
2018
Q3
$349K Sell
12,300
-12,400
-50% -$296K ﹤0.01% 3548
2018
Q2
$352K Hold
24,700
﹤0.01% 3555
2018
Q1
$352K Buy
24,700
+5,700
+30% +$81.6K ﹤0.01% 3555
2017
Q4
$234K Buy
+19,000
New +$268K ﹤0.01% 3945

Other funds holding EVH

Wolverine Trading's EVH Position: Q1 2025 in Review

Wolverine Trading sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 37,065 shares — an estimated $407K sold.

Wolverine Trading first reported a position in EVH in Q1 2017 and held it in 11 quarters. The position peaked at $456K in Q2 2018. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Wolverine Trading reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 37,065 Evolent Health shares in Q1 2025, an estimated $407K.
  • Wolverine Trading first reported a position in Evolent Health in Q1 2017 and held it in 11 quarters.
  • Wolverine Trading's Evolent Health position peaked at $456K in Q2 2018.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.